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Reuterin, which comprises β-hydroxypropionaldehyde and its hydrated and dimeric forms, is a small 
valuable compound that can be used in a myriad of applications. Because of its antimicrobial 
activity, reuterin can be applied as such in food preservation or produced in situ by the reuterin-
producing strain, Lactobacillus reuteri, in probiotic formulas. Reuterin can also be used as a 
precursor for the synthesis of several chemicals such as acrolein, acrylic acid and 1,3-propanediol 
[1] and as an alternative to glutaraldehyde in the sterilization and fixation of prostheses derived from 
biological tissue [2]. 
Reuterin can be produced via traditional chemistry and by bacterial bioconversion. The bio-process 
is based on a simple and clean single enzymatic step, which converts the renewable and cheap 
resource glycerol with high yield into β-hydroxypropionaldehyde. We have studied this 
bioconversion by using viable cell suspensions of Lactobacillus reuteri and partially optimized the 
process for the production of pure reuterin. 
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We have also assessed the antifungal activity of reuterin, which was found to inhibit the growth 
of a range of spoilage fungi (Penicillium, Aspergillus etc.) and also Bacillus sp. on an agar-plate 
assay with reuterin added to a flour-containing medium. Contrary to the well studied antibacterial 
activities, the antifungal metabolites of lactic acid bacteria remain far less explored [3]. Reuterin 
could act as a model bio-active molecule in this context. 
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